1.Ruptured bleeding of liver cancer Ruptured bleeding of primary liver cancer is a serious and fatal common complication of liver cancer patients, with an incidence rate of about 5.46%-19.8%.
It is also one of the main causes of death of liver cancer patients, accounting for 9%-10% of the causes of death of liver cancer, and occupies the 4th place among the causes of death of liver cancer. Because of the sudden and rapid onset of the disease, it is often accompanied by shock. Therefore, it is difficult to treat and has poor prognosis. If not actively treated, most patients will die rapidly. 2.Hepatic encephalopathy Hepatic encephalopathy, also known as hepatic coma or hepatic brain syndrome, is a common complication of end-stage liver cancer. It is characterized by dysfunction of central nervous system and metabolic disorder, with mental retardation, consciousness impairment, neurological signs and liver damage as the main clinical findings. Ascites is a kind of restrictive edema, which refers to the accumulation of excessive fluid in the abdominal cavity. Under normal circumstances, there is a small amount of fluid in the abdominal cavity, about 200 ml, which acts as a lubricant. When the amount of fluid exceeds 200 ml, it can be called ascites, and when the fluid in the abdominal cavity exceeds 150 ml, a positive mobile turbid sound can be found on physical examination. The mechanism of ascites is complex and is related to the imbalance of fluid exchange inside and outside the body and the imbalance of fluid exchange inside and outside the blood vessels. A variety of malignant tumors can appear ascites, and the ascites appearing on the basis of tumor is called malignant ascites. Both primary and secondary hepatocellular carcinoma are often accompanied by ascites, which is closely related to liver cirrhosis and portal hypertension in patients with hepatocellular carcinoma. 4.Infection and cancer fever Complications of hepatocellular carcinoma can be caused by hepatocellular carcinoma itself or often combined with cirrhosis, or caused by anti-tumor therapy. Jaundice Jaundice is one of the common complications in patients with middle and late stage liver cancer, with a complication rate of about 29.6%-37.5%. Jaundice is a clinical manifestation of yellow staining of sclera, skin, mucous membrane and body fluid caused by the increase of plasma bilirubin concentration when bilirubin metabolism is impaired. Bilirubin comes from aging red blood cells in the body, and its production, metabolism and excretion are closely related to the liver.
According to the cause of jaundice can be divided into hemolytic jaundice, hepatocellular jaundice and obstructive jaundice.